A comparative analysis of immunogenicity and safety of an enterovirus 71 vaccine between children aged 3-5 years and infants aged 6-35 months

• Main Authors: Wei Gu (Author), Gang Zeng (Author), Yue-mei Hu (Author), Yuan-Sheng Hu (Author), Ying Zhang (Author), Ya-ling Hu (Author), Yang Wang (Author), Jing-Xin Li (Author), Feng-Cai Zhu (Author)
• Format: Book
• Published: Taylor & Francis Group, 2018-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The Sinovac enterovirus 71 (EV71) vaccine has shown good safety, immunogenicity, and efficacy in infants aged 6-35 months, whom are considered as the priority of the target population. However, 3-5 years old children accounted for approximately 30% of HFMD cases and are also worth our at...